Cargando…
Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients
Colorectal cancer (CRC) is the third and second most common cancer in males and females worldwide, respectively. Spondin-2 is a conserved secreted extracellular matrix protein and a candidate cancer biomarker. Here we found that Spondin-2 mRNA was upregulated in CRC tissues using quantitative RT-PCR...
Autores principales: | Zhang, Qian, Wang, Xiao-Qing, Wang, Jie, Cui, Shu-Jian, Lou, Xiao-Min, Yan, Bing, Qiao, Jie, Jiang, Ying-Hua, Zhang, Li-Jun, Yang, Peng-Yuan, Liu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558138/ https://www.ncbi.nlm.nih.gov/pubmed/25945835 |
Ejemplares similares
-
Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma
por: Feng, Ying, et al.
Publicado: (2018) -
Upregulated NLGN1 predicts poor survival in colorectal cancer
por: Yu, Qian, et al.
Publicado: (2021) -
Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome
por: Tian, Haiying, et al.
Publicado: (2017) -
Spondin2 is a new prognostic biomarker for lung adenocarcinoma
por: Yuan, Xiaopeng, et al.
Publicado: (2017) -
R‐spondin‐3 is an oncogenic driver of poorly differentiated invasive breast cancer
por: ter Steege, Eline J, et al.
Publicado: (2022)